5.3332 USD
-0.01 (-0.13%)
Taking everything into account, STRM scores 1 out of 10 in our fundamental rating. STRM was compared to 34 industry peers in the Health Care Technology industry. Both the profitability and financial health of STRM have multiple concerns. STRM has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- STRM had negative earnings in the past year.
- STRM had a negative operating cash flow in the past year.
- In the past 5 years STRM reported 4 times negative net income.
- In the past 5 years STRM always reported negative operating cash flow.
1.2 Ratios
- STRM's Return On Assets of -25.30% is in line compared to the rest of the industry. STRM outperforms 41.67% of its industry peers.
- Looking at the Return On Equity, with a value of -82.00%, STRM is doing worse than 69.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.3% | ||
| ROE | -82% | ||
| ROIC | N/A |
ROA(3y)-30.62%
ROA(5y)-20.25%
ROE(3y)-71.39%
ROE(5y)-46.33%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- STRM has a Gross Margin (48.29%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of STRM has declined.
- STRM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.29% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.74%
GM growth 5Y-3.21%
2. Health
2.1 Basic Checks
- STRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, STRM has more shares outstanding
- STRM has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for STRM is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -5.15, we must say that STRM is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of STRM (-5.15) is worse than 75.00% of its industry peers.
- STRM has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.18, STRM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.15 |
ROIC/WACCN/A
WACC10.21%
2.3 Liquidity
- STRM has a Current Ratio of 0.27. This is a bad value and indicates that STRM is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.27, STRM is doing worse than 91.67% of the companies in the same industry.
- STRM has a Quick Ratio of 0.27. This is a bad value and indicates that STRM is not financially healthy enough and could expect problems in meeting its short term obligations.
- STRM's Quick ratio of 0.27 is on the low side compared to the rest of the industry. STRM is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.27 | ||
| Quick Ratio | 0.27 |
3. Growth
3.1 Past
- STRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -127.84%.
- Looking at the last year, STRM shows a very negative growth in Revenue. The Revenue has decreased by -14.88% in the last year.
- Measured over the past years, STRM shows a quite strong growth in Revenue. The Revenue has been growing by 8.60% on average per year.
EPS 1Y (TTM)-127.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.52%
Revenue 1Y (TTM)-14.88%
Revenue growth 3Y0.99%
Revenue growth 5Y8.6%
Sales Q2Q%11.09%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y15.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- STRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STRM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for STRM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STREAMLINE HEALTH SOLUTIONS / STRM FAQ
What is the fundamental rating for STRM stock?
ChartMill assigns a fundamental rating of 1 / 10 to STRM.
What is the valuation status of STREAMLINE HEALTH SOLUTIONS (STRM) stock?
ChartMill assigns a valuation rating of 0 / 10 to STREAMLINE HEALTH SOLUTIONS (STRM). This can be considered as Overvalued.
Can you provide the profitability details for STREAMLINE HEALTH SOLUTIONS?
STREAMLINE HEALTH SOLUTIONS (STRM) has a profitability rating of 0 / 10.
What is the financial health of STREAMLINE HEALTH SOLUTIONS (STRM) stock?
The financial health rating of STREAMLINE HEALTH SOLUTIONS (STRM) is 1 / 10.